SMSbiotech, Inc

Welcome to the Future of Medicine and Research

 

Cutting Edge

Stem Cell Technology

 

Groundbreaking Products

Click HERE to read more on our Proposal for the treatment of COVID-19 and to access COVID-19 related resources.

Stem Cell Based Enabling Technology Company

SMSbiotech, Inc. is a California-based biotech company. Our goal is to revolutionize how the life sciences industry explores, examines, assesses and manipulates cells, drugs and toxins. SMSbiotech stem cell technology will lead to the development of more efficient and relevant medicines that will serve a broad spectrum of patients and reduce the overall costs of healthcare.

SMSbiotech:

  • Provides a novel, patented approach that can produce unique human autologous and allogeneic adult Small Mobile Stem (SMS) cells at an industrial scale.
  • Manufactures complex human extracellular matrices (ECMs).
  • Manufactures ECMs for therapeutic purposes, such as wound healing.
  • Produces human ECMs with unique angiogenic capabilities for use in research and development.

The Science

Stem cell enabling technology delivering human extracellular matrices (ECM) derived from Small Mobile Stem (SMS) cells.

learn more

The Challenges

Tissue degeneration is at the root of many chronic diseases such as COPD, ARDS, and chronic wounds.

learn more

The Solutions

Cutting edge technology addressing the two essential components of living tissue; cells and extracellular matrix.

learn more

Our Mission

Democratizing the application of adult stem cell technologies for human health.

learn more

Who We Are

SMSbiotech was founded based on its revolutionary adult stem cell research. Through a combination of hard work and over three decades of experience in research and applications, we have been able to patent a new platform technology. Our technology will change the way that life science industries approach the research of cells, drugs and toxins by providing a wide spectrum of medical applications.

learn more